Literature DB >> 11872611

Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients.

Marc Jacobsen1, Sabine Cepok, Elfriede Quak, Michael Happel, Rami Gaber, Andreas Ziegler, Sabine Schock, Wolfgang H Oertel, Norbert Sommer, Bernhard Hemmer.   

Abstract

Multiple sclerosis is a chronic inflammatory demyelinating disease of the CNS. Although the aetiology of multiple sclerosis is still unknown, it is widely believed that T cells play a central role in its pathogenesis. To identify and characterize disease-relevant T cells, we analysed CD4+ and CD8+ T cells freshly isolated from the CSF and peripheral blood of 36 multiple sclerosis patients for their T-cell receptor variable beta (TCRBV) chain repertoire. In most patients, we found significant overexpression of individual TCRBV chains on CD8+ T cells from CSF compared with peripheral blood. In contrast, only a few multiple sclerosis patients showed differences between the two compartments in TCRBV expression on CD4+ T cells. The overexpression of specific TCRBV chains on CD8+ T cells was found to be stable over several months in selected patients and involved mainly T cells with a memory phenotype. In two patients studied, individual TCRBV chain overexpression was found to be caused by the expansion of T cell populations with identical or highly similar rearranged T-cell receptor beta- and alpha-chain sequences, which were not found among peripheral blood CD8+ T cells. Our findings demonstrate selective enrichment of memory CD8+ T cells in the CSF of multiple sclerosis patients, suggesting a role for these CD8+ T cells in the pathogenesis of multiple sclerosis. Our study provides a basis for future trials to identify disease-associated antigens and disease pathogenesis in multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11872611     DOI: 10.1093/brain/awf059

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  76 in total

Review 1.  T-cell based immunotherapy in experimental autoimmune encephalomyelitis and multiple sclerosis.

Authors:  Kate O'Brien; Bruno Gran; Abdolmohamad Rostami
Journal:  Immunotherapy       Date:  2010-01       Impact factor: 4.196

Review 2.  Neuroimmunotherapies Targeting T Cells: From Pathophysiology to Therapeutic Applications.

Authors:  Stefan Bittner; Heinz Wiendl
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

3.  A transgenic model of central nervous system autoimmunity mediated by CD4+ and CD8+ T and B cells.

Authors:  Ana C Anderson; Rucha Chandwaskar; David H Lee; Jenna M Sullivan; Adam Solomon; Roselynn Rodriguez-Manzanet; Bernhard Greve; Raymond A Sobel; Vijay K Kuchroo
Journal:  J Immunol       Date:  2012-01-25       Impact factor: 5.422

4.  Expression of HERV-Fc1, a human endogenous retrovirus, is increased in patients with active multiple sclerosis.

Authors:  Magdalena Janina Laska; Tomasz Brudek; Kari Konstantin Nissen; Tove Christensen; Anné Møller-Larsen; Thor Petersen; Bjørn Andersen Nexø
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

5.  Immune regulatory CNS-reactive CD8+T cells in experimental autoimmune encephalomyelitis.

Authors:  Nathan R York; Jason P Mendoza; Sterling B Ortega; Andrew Benagh; Andrew F Tyler; Mihail Firan; Nitin J Karandikar
Journal:  J Autoimmun       Date:  2010-02-20       Impact factor: 7.094

6.  Altered naive CD4 and CD8 T cell homeostasis in patients with relapsing-remitting multiple sclerosis: thymic versus peripheral (non-thymic) mechanisms.

Authors:  D A Duszczyszyn; J D Beck; J Antel; A Bar-Or; Y Lapierre; V Gadag; D G Haegert
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

7.  Characterization of a severe parenchymal phenotype of experimental autoimmune encephalomyelitis in (C57BL6xB10.PL)F1 mice.

Authors:  Michael D Carrithers; Lisette M Carrithers; Jan Czyzyk; Octavian Henegariu
Journal:  J Neuroimmunol       Date:  2007-05-18       Impact factor: 3.478

8.  High-Resolution Expression Profiling of Peripheral Blood CD8+ Cells in Patients with Multiple Sclerosis Displays Fingolimod-Induced Immune Cell Redistribution.

Authors:  Luisa Roch; Michael Hecker; Jörg Friess; Ines Charlotte Angerer; Dirk Koczan; Brit Fitzner; Ina Schröder; Kristin Flechtner; Hans-Jürgen Thiesen; Stefanie Meister; Alexander Winkelmann; Uwe Klaus Zettl
Journal:  Mol Neurobiol       Date:  2016-09-08       Impact factor: 5.590

9.  CD8+ T cells cause disability and axon loss in a mouse model of multiple sclerosis.

Authors:  Chandra Deb; Reghann G Lafrance-Corey; William F Schmalstieg; Brian M Sauer; Huan Wang; Christopher L German; Anthony J Windebank; Moses Rodriguez; Charles L Howe
Journal:  PLoS One       Date:  2010-08-30       Impact factor: 3.240

10.  B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity.

Authors:  Tomasz Brudek; Tove Christensen; Lars Aagaard; Thor Petersen; Hans J Hansen; Anné Møller-Larsen
Journal:  Retrovirology       Date:  2009-11-16       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.